The closing price of AMN Healthcare Services Inc. (NYSE: AMN) was $58.29 for the day, up 2.62% from the previous closing price of $56.80. In other words, the price has increased by $+1.49 from its previous closing price. On the day, 624009 shares were traded. AMN stock price reached its highest trading level at $58.31 during the session, while it also had its lowest trading level at $56.04.
Ratios:
Our analysis of AMN’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 40.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.23. For the most recent quarter (mrq), Quick Ratio is recorded 1.28 and its Current Ratio is at 1.28. In the meantime, Its Debt-to-Equity ratio is 1.62 whereas as Long-Term Debt/Eq ratio is at 1.61.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on December 06, 2023, initiated with a Mkt Outperform rating and assigned the stock a target price of $85.
Jefferies Downgraded its Buy to Hold on November 03, 2023, whereas the target price for the stock was revised from $115 to $70.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 04 ’24 when Fontenot Teri G. bought 1,732 shares for $57.64 per share. The transaction valued at 99,832 led to the insider holds 4,558 shares of the business.
HARRIS R JEFFREY bought 2,640 shares of AMN for $150,401 on Feb 29 ’24. The Director now owns 54,237 shares after completing the transaction at $56.97 per share. On Feb 29 ’24, another insider, FOLETTA MARK G, who serves as the Director of the company, bought 500 shares for $56.90 each. As a result, the insider paid 28,450 and bolstered with 8,573 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMN now has a Market Capitalization of 2.21B and an Enterprise Value of 3.53B. As of this moment, AMN’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.03, and their Forward P/E ratio for the next fiscal year is 12.72. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.58 while its Price-to-Book (P/B) ratio in mrq is 2.65. Its current Enterprise Value per Revenue stands at 0.93 whereas that against EBITDA is 7.06.
Stock Price History:
Over the past 52 weeks, AMN has reached a high of $112.44, while it has fallen to a 52-week low of $53.77. The 50-Day Moving Average of the stock is 71.04, while the 200-Day Moving Average is calculated to be 83.26.
Shares Statistics:
AMN traded an average of 701.05K shares per day over the past three months and 989.88k shares per day over the past ten days. A total of 37.81M shares are outstanding, with a floating share count of 37.65M. Insiders hold about 0.63% of the company’s shares, while institutions hold 104.99% stake in the company. Shares short for AMN as of Feb 15, 2024 were 4.33M with a Short Ratio of 6.18, compared to 4.07M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.46% and a Short% of Float of 17.23%.
Earnings Estimates
The firm’s stock currently is rated by 8 analysts. On average, analysts expect EPS of $0.98 for the current quarter, with a high estimate of $1.14 and a low estimate of $0.8, while EPS last year was $2.49. The consensus estimate for the next quarter is $0.93, with high estimates of $1 and low estimates of $0.85.
Analysts are recommending an EPS of between $4.4 and $3.61 for the fiscal current year, implying an average EPS of $3.96. EPS for the following year is $4.73, with 9 analysts recommending between $5.38 and $4.16.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 8 analysts. It ranges from a high estimate of $821M to a low estimate of $811.69M. As of the current estimate, AMN Healthcare Services Inc.’s year-ago sales were $1.13B, an estimated decrease of -27.50% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $780.31M, a decrease of -21.30% over than the figure of -$27.50% in the same quarter last year. There is a high estimate of $788.97M for the next quarter, whereas the lowest estimate is $771.72M.
A total of 9 analysts have provided revenue estimates for AMN’s current fiscal year. The highest revenue estimate was $3.31B, while the lowest revenue estimate was $3.11B, resulting in an average revenue estimate of $3.19B. In the same quarter a year ago, actual revenue was $3.79B, down -15.80% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $3.31B in the next fiscal year. The high estimate is $3.41B and the low estimate is $3.16B. The average revenue growth estimate for next year is up 3.90% from the average revenue estimate for this year.
